Table 3 Use of antithrombotic drugs at diagnosis, overall and according to CHA2DS2-VASc scores of 0 or 1 and 2–9
Antiplatelet druga | All patients (N = 5072) | Patients with CHA2DS2-VASc score of 0 or 1 (N = 665) | Patients with CHA2DS2-VASc score 2–9 (N = 4289) |
|---|---|---|---|
Acetylsalicylic acid (Aspirin/ASA) | 501 (9.9) | 28 (4.2) | 465 (10.8) |
ADP receptor/P2Y12 inhibitor | 248 (4.9) | 13 (2.0) | 231 (5.4) |
Glycoprotein IIb/IIIa inhibitor | 9 (0.2) | 2 (0.3) | 6 (0.1) |
Prostaglandin analogue | 71 (1.4) | 5 (0.8) | 66 (1.5) |
Other antiplatelet | 8 (0.2) | 2 (0.3) | 6 (0.1) |